Drugscan Revenue, Growth & Competitor Profile

DBA DRUGSCAN, INC

Company Profile & Annual Report for Drugscan

Access the complete profile.

Drugscan Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	200 Precision Road - Suite 200 Horsham, PA 19044

Note: Revenues for privately held companies are statistical evaluations.


Drugscan's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Drugscan's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Drugscan is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Drugscan Annual Revenue and Growth Rate

Drugscan	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Drugscan's revenues are gauged from an analysis of company filings.

Drugscan's Income Statement (based on Industry Averages)

Drugscan P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Drugscan is developing and marketing. Drugscan doesn't have any recent trademark applications, indicating Drugscan is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
VALIDATERX Providing an online website for generating reports for medical providers that compare patient drug test results with the patient's Prescription Drug Monitoring Program drug dispensing records	01/06/2022
CONFIDENTRX Providing an online website for clinical support for prescribing controlled substances including scheduling support for risk assessments, controlled substance agreements, prescription drug monitoring program checks, drug testing, logging patient aberrant drug-related behaviors and early refill prescription requests	01/06/2022
VIRASCAN Medical diagnostic and molecular testing of specimens for the presence of infectious diseases and viruses	12/02/2020

See all trademarks and details in the Full Report.

Market Share of Drugscan's Largest Competitors

A competitive analysis shows these companies are in the same general field as Drugscan, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Drugscan. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
NATIONAL MEDICAL SERVICES	Horsham, PA	100
DRUGSCAN	Horsham, PA	36
BROOKSIDE CLINICAL LAB	Aston, PA	10
ATLANTIC DIAGNOSTIC LABORATORIES LL	Bensalem, PA	10
ANSLEY MEDICAL MANAGEMENT GROUP	Melrose Park, PA	9
PAIN & SURGICAL CENTER OF LANGHORNE	Langhorne, PA	5

Future Competition: Drugscan's Fastest Growing Competitors

These companies are in the same general field as Drugscan and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)